The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future

The rapid advancement of emerging genomics technologies and their application for assessing safety and efficacy of FDA-regulated products require a high standard of reliability and robustness supporting regulatory decision-making in the FDA. To facilitate the regulatory application, the FDA implemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Joshua, Thakkar, Shraddha, Gong, Binsheng, Tong, Weida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973466/
https://www.ncbi.nlm.nih.gov/pubmed/27116022
http://dx.doi.org/10.1208/s12248-016-9917-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973466/
https://www.ncbi.nlm.nih.gov/pubmed/27116022
http://dx.doi.org/10.1208/s12248-016-9917-y

Ejemplares similares